LncRNA MALAT‐1 is frequently revelated to regulate NSCLC metastasis.19 LncRNA MEG3 is reported to regulate cisplatin resistance of NSCLC.20 MetaLnc9 promotes NSCLC metastasis via activation of AKT/mTOR pathway.21 LncRNA VELUCT regulates NSCLC cell viability.22 Knockdown of LINC01614 inhibits NSCLC progression.23 Here, MTOR is linked to non-small cell lung carcinoma.